Cargando…
Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
BACKGROUND: Cognitive impairment is a major problem in elderly, affecting quality of life. Pre-clinical studies show that MMFS-01, a synapse density enhancer, is effective at reversing cognitive decline in aging rodents. OBJECTIVE: Since brain atrophy during aging is strongly associated with both co...
Autores principales: | Liu, Guosong, Weinger, Jason G., Lu, Zhong-Lin, Xue, Feng, Sadeghpour, Safa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927823/ https://www.ncbi.nlm.nih.gov/pubmed/26519439 http://dx.doi.org/10.3233/JAD-150538 |
Ejemplares similares
-
Money Market Funds (MMFs) and the Covid-19 pandemic: Has the MMLF benefited money markets?
por: Apergis, Nicholas
Publicado: (2022) -
Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Xiao, Jinzhong, et al.
Publicado: (2020) -
Comparison between Golnar product and placebo in heavy menstrual bleeding: A double-blind randomized clinical trial
por: Yousefi, Fatemeh, et al.
Publicado: (2020) -
Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study
por: Zhu, Weiwei, et al.
Publicado: (2014) -
Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial
por: Press, Yan, et al.
Publicado: (2021)